ロード中...
Systems approach to the pharmacological actions of HDAC inhibitors reveals EP300 activities and convergent mechanisms of regulation in diabetes
Given the skyrocketing costs to develop new drugs, repositioning of approved drugs, such as histone deacetylase (HDAC) inhibitors, may be a promising strategy to develop novel therapies. However, a gap exists in the understanding and advancement of these agents to meaningful translation for which ne...
保存先:
| 出版年: | Epigenetics |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5788408/ https://ncbi.nlm.nih.gov/pubmed/28886276 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15592294.2017.1371892 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|